2018-10-01
Treatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment
Publication
Publication
Annals of Oncology , Volume 29 p. viii281- viii282
Additional Metadata | |
---|---|
doi.org/10.1093/annonc/mdy284.022, hdl.handle.net/1765/125543 | |
Annals of Oncology | |
Organisation | Erasmus MC Cancer Institute |
Robbrecht, D.G. (D. G.), van Soest, R. J., Tannock, I., Oudard, S., Tombal, B., Eisenberger, M., … de Wit, R. (2018). Treatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment. Annals of Oncology, 29, viii281–viii282. doi:10.1093/annonc/mdy284.022 |